PBZ OTC Pyribenzamine Antihistamine Cream Wins 2025 Product of the Year USA

PBZ OTC Pyribenzamine Antihistamine Cream Wins Major Recognition

Kingsway Pharmaceuticals has made headlines after its PBZ OTC Pyribenzamine Antihistamine Cream was named the 2025 Product of the Year USA in the Immediate Relief category. This prestigious recognition solidifies the cream's position as a groundbreaking solution for itch relief, determined through a national study involving over 40,000 American shoppers in conjunction with Kantar, a leading global consumer research firm.

For years, consumers have sought effective and convenient relief for itching, often resorting to oral medications or traditional topical treatments. The PBZ OTC Pyribenzamine Cream stands out because it is the first topical antihistamine to hit the over-the-counter market in decades—moving away from its previous prescription-only status. The innovative formula combines tripelennamine, a potent antihistamine, which is effective against various types of itching including insect bites, poison ivy, sunburn, and more. Notably, it is steroid-free, making it suitable for all family members aged two and above.

Benjamin Blessing, the COO of Kingsway Pharmaceuticals, expressed his excitement about the award: "We're thrilled that PBZ OTC Pyribenzamine Antihistamine Cream has been recognized by consumers as a 2025 Product of the Year winner. This award validates our commitment to innovation. By listening to consumers and leveraging cutting-edge pharmaceutical technology, we've created an innovative product that provides immediate relief and fits seamlessly into our customers' daily lives."

The Product of the Year recognition is not just a badge of honor; it is a powerful endorsement from consumers themselves. As the largest consumer-voted awards program focused on product innovation, it has been active in the U.S. for 17 years and has helped guide consumers toward the best products available in the market. The distinctive red seal has become a trusted sign for shoppers looking for highly rated new products, both online and in-store.

PBZ OTC Pyribenzamine Cream's win comes at a time when the market demands effective, easy-to-use, and long-lasting solutions for common complaints like itching. The cream's targeted relief, combined with its ease of application and non-greasy feel, provides an appealing alternative to traditional treatment options. The immediate relief it promises aligns perfectly with what modern consumers are increasingly looking for in their health and wellness routines.

In terms of marketing and consumer engagement, Kingsway Pharmaceuticals plans to leverage this Product of the Year seal prominently in their campaigns. By highlighting the consumer-voted nature of the award, they aim to build trust and create greater awareness of the cream's innovative qualities and its capability to deliver quick itch relief.

To see how well this product performs in stores, shoppers can find PBZ OTC Pyribenzamine Antihistamine Cream at retailers such as Target and on the Kingsway Pharmaceuticals website, www.kingswaypharma.com.

The significance of this recognition extends beyond Kingsway Pharmaceuticals and its product; it reflects a growing trend among manufacturers to create solutions that address real consumer needs. The commitment to quality, research, and innovation that drove the creation of this cream is shared by many in the industry, promising a brighter future for consumers seeking better solutions for their health concerns.

For a full list of winners from the 2025 Product of the Year awards, visit productoftheyearusa.com.

About Kingsway Pharmaceuticals: Kingsway Pharmaceuticals is dedicated to offering innovative health solutions that enhance people's quality of life. With a focus on trusted products designed for specific health needs, the company remains committed to upholding rigorous research and quality standards. They aim to empower individuals to achieve better health outcomes, making daily life easier and more enjoyable.